Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ORAGENICS INC Director's Dealing 2013

Oct 22, 2013

35380_dirs_2013-10-22_6c571f0f-a84c-4865-a4a4-e3a06381fe9a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAGENICS INC (OGEN)
CIK: 0001174940
Period of Report: 2013-10-18

Reporting Person: Telling Fred (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-10-18 Common Stock A 33185 Acquired 190777 Direct

Footnotes

F1: Represents a performance award of 33,185 shares made in connection with, and as part of, the previously approved long-term compensation component of the director compensation program adopted by the Company and the award agreement with the reporting individual. The award was made under the Company's 2012 Equity Incentive Plan (the "Plan") and was based upon the determination that a specified performance goal related to the Company's entering into a new collaboration agreement had been achieved. The award determination was made on October 18, 2013, and the closing price of the Company's stock on such date was $2.99.